These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28289281)

  • 21. Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial.
    Quintana DS; Westlye LT; Alnæs D; Rustan ØG; Kaufmann T; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
    Psychoneuroendocrinology; 2016 Jul; 69():180-8. PubMed ID: 27107209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men.
    Quintana DS; Westlye LT; Smerud KT; Mahmoud RA; Andreassen OA; Djupesland PG
    Horm Behav; 2018 Jun; 102():85-92. PubMed ID: 29750971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
    Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S
    Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Verbalis JG; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
    Schizophr Res; 2016 Apr; 172(1-3):165-8. PubMed ID: 26879587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osmotic mechanisms regulating cerebrospinal fluid vasopressin and oxytocin in the conscious rat.
    Morris M; Barnard RR; Sain LE
    Neuroendocrinology; 1984 Nov; 39(5):377-83. PubMed ID: 6514130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats.
    Iványi T; Dohanics J; Verbalis JG
    Neuroendocrinology; 1995 Apr; 61(4):412-20. PubMed ID: 7783854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study.
    Daughters K; Manstead AS; Hubble K; Rees A; Thapar A; van Goozen SH
    PLoS One; 2015; 10(12):e0145104. PubMed ID: 26669935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consistency and efficacy of two methods of intranasal oxytocin application in dogs.
    Schaebs FS; Deschner T; Range F; Karl S; Marshall-Pescini S
    Domest Anim Endocrinol; 2020 Jul; 72():106436. PubMed ID: 32114215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between central and peripheral oxytocin concentrations: a systematic review and meta-analysis protocol.
    Valstad M; Alvares GA; Andreassen OA; Westlye LT; Quintana DS
    Syst Rev; 2016 Mar; 5():49. PubMed ID: 27037015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of oxytocin into blood and cerebrospinal fluid by electrical stimulation of the hypothalamus or neural lobe in the rat.
    Jones PM; Robinson IC; Harris MC
    Neuroendocrinology; 1983 Dec; 37(6):454-8. PubMed ID: 6657003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of oxytocin concentrations in the plasma and cerebrospinal fluid of lactating rhesus monkeys (Macaca mulatta): evidence for functionally independent oxytocinergic pathways in primates.
    Amico JA; Challinor SM; Cameron JL
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1531-5. PubMed ID: 2229310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal oxytocin in rhesus monkeys alters brain networks that detect social salience and reward.
    Parr LA; Mitchell T; Hecht E
    Am J Primatol; 2018 Oct; 80(10):e22915. PubMed ID: 30295946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin.
    Oppong-Damoah A; Zaman RU; D'Souza MJ; Murnane KS
    Horm Behav; 2019 Feb; 108():20-29. PubMed ID: 30593782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport of oxytocin to the brain after peripheral administration by membrane-bound or soluble forms of receptors for advanced glycation end-products.
    Munesue SI; Liang M; Harashima A; Zhong J; Furuhara K; Boitsova EB; Cherepanov SM; Gerasimenko M; Yuhi T; Yamamoto Y; Higashida H
    J Neuroendocrinol; 2021 Mar; 33(3):e12963. PubMed ID: 33733541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salivary vasopressin increases following intranasal oxytocin administration.
    Weisman O; Schneiderman I; Zagoory-Sharon O; Feldman R
    Peptides; 2013 Feb; 40():99-103. PubMed ID: 23246527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration.
    Francis SM; Kirkpatrick MG; de Wit H; Jacob S
    Psychoneuroendocrinology; 2016 Dec; 74():92-100. PubMed ID: 27592327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury.
    Meidahl AC; Eisenried A; Klukinov M; Cao L; Tzabazis AZ; Yeomans DC
    Headache; 2018 Apr; 58(4):545-558. PubMed ID: 29266199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of estradiol and progesterone administration upon the circadian rhythm of oxytocin in the cerebrospinal fluid of rhesus monkeys.
    Amico JA; Janosky JE; Cameron JL
    Neuroendocrinology; 1990 May; 51(5):543-51. PubMed ID: 2112731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques (Macaca mulatta).
    Chang SW; Barter JW; Ebitz RB; Watson KK; Platt ML
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):959-64. PubMed ID: 22215593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding.
    Russell J; Maguire S; Hunt GE; Kesby A; Suraev A; Stuart J; Booth J; McGregor IS
    Psychoneuroendocrinology; 2018 Jan; 87():83-92. PubMed ID: 29049935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.